BRONCUS-B(02216) Stock Price Today | Quotes & News

HK Stock MarketDetailed Quotes

02216 BRONCUS-B

Watchlist

1.870
+0.290+18.35%

Not Open Apr 24 16:08 CST

982.76MMarket Cap-8.27P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

BRONCUS-B: Annual Report 2024
HKEXApr 24 05:22 ET · Announcements
Kunbo Medical-B (02216): The core product BroncAblate Smart single-use pulmonary radiofrequency ablation catheter has been approved for sale in China.
Kunbo Medical-B (02216) announced that the company's core product, the first global self-developed radiofrequency through natural cavities...
Zhitong FinanceApr 21 07:19 ET
Express News | Broncus Holding Corp - Broncablate Disposable Lung Radiofrequency- Ablation Catheter Approved for Marketing in China by Nmpa
ReutersApr 21 07:00 ET
The industry is hotly discussing the future trends of nuclear medicine, will Hybrid NewCo become a new model for the RDC Industry to venture abroad? | Industry Observation
① Today, the 2025 Future XDC New Drug Conference is held in Chengdu; ② Executives from companies such as Baillie Tianheng and Kelun Botai, along with numerous experts and scholars in the industry, will jointly discuss cutting-edge technologies in ADC/nuclear drug development, overseas strategies, and other Topics.
cls.cnApr 17 08:57 ET
Everbright: Import substitution is expected to accelerate, pay attention to the rising market share of domestic surgical robots.
Everbright stated that the import substitution is expected to accelerate, paying attention to the rise in market share of domestic surgical robots.
Zhitong FinanceApr 10 19:17 ET
Kunbo Medical-B (02216.HK) spent 0.144 million Hong Kong dollars on April 9 to repurchase 0.15 million shares.
On April 9, Gelonghui announced that Kunbo Medical-B (02216.HK) spent 0.144 million HKD to repurchase 0.15 million shares.
Gelonghui FinanceApr 9 07:05 ET

Comments

Geertruida

Sep 26, 2021 20:54

$BRONCUS-B (02216.HK)$ Kunbo Medical's Hong Kong stock market breaks, the first listing closes down 19.79%
Kunbo Medical, an interventional medical device company, was listed on the Hong Kong Stock Exchange on Friday with an issue price of HK$18.7 and a net fund-raising of HK$1.552 billion. The first listing closed down 19.79%; excluding handling fees, the first-hand book value was HK$1,850. The cornerstone investors of Kunbo Medical include Snow Lake Capital, Qifeng Capital, etc.

Rebecca Augustine

Sep 14, 2021 21:00

$BRONCUS-B (02216.HK)$ is the leader of a small segment of the track. This is its main premium space. The "outbreak" of $HELENS (09869.HK)$ was once seen by the market as a sign of a new recovery. I think we can pay attention to it. If you are more cautious, you can look at the dark market and make a profit if it rises. Generally, the performance on the first day will not be too bad.